Ann: Phase I Clinical Trial Dosing Update No 3, page-62

  1. 1,435 Posts.
    lightbulb Created with Sketch. 190
    AGN CEO just exercised her options of 300k worth just before results. AGN about to prove up NYR mechanism of action in humans and at the same time in 1-3 weeks final cohorts for safety in humans get announced. AGN about up move towards a 300-400 million market cap. Going to be interesting few weeks ahead and management and major shareholders increasing their stakes
    Last edited by Bendunstan: 03/06/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
34.0¢
Change
0.010(3.03%)
Mkt cap ! $71.71M
Open High Low Value Volume
33.5¢ 34.5¢ 33.5¢ $174.4K 513.2K

Buyers (Bids)

No. Vol. Price($)
1 40000 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 97442 5
View Market Depth
Last trade - 15.59pm 28/07/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.